THE EFFECT OF COMBINED CHEMOTHERAPY IN WOMEN WITH BREAST CANCER ON THE STIFFNESS OF THE COMMON CAROTID ARTERY AND PULSE WAVE PARAMETERS STUDIED BY ECHO TRACKING

Author:

Zairova A. R.1ORCID,Rogoza A. N.2ORCID,Avalyan A. A.2ORCID,Oshchepkova E. V.3ORCID

Affiliation:

1. Research Institute of Cardiology named after A.L. Myasnikova; Federal State Budgetary Institution National Cardiology Research Center Ministry of Health of the Russian Federation

2. Federal State Budgetary Institution National Cardiology Research Center Ministry of Health of the Russian Federation

3. Federal State Budgetary Institution Scientific Center for Cardiology, Ministry of Health of the Russian Federation

Abstract

The aim of the study was to study the effect of combined chemotherapy in women with breast cancer (BC) on arterial stiffness and pulse wave by ultrasound examination of the common carotid artery (CCA) using echo tracking technology.Materials and methods. 40 women with triple negative breast cancer aged 27 to 75 years (47.5±12.0) were examined initially and after chemotherapy with the inclusion of anthracyclines (doxorubicin), taxanes (paclitaxel) and platinum derivatives (cisplatin). Arterial stiffness parametres (β-stiffness index, Ep-elastic modulus, AC-arterial compliance, PWV-pulse wave velocity) and AI - augmentation index were studied in the distal CCA at a distance of 2 cm from bifurcation on an Aloka ProSound α7 ultrasound machine using echo tracking technology.Results. After combined chemotherapy the parameters b, Ep, PWV not significantly changed (9,3±4,3 vs 8,9±4,5, р=0,63 ;128,73±65,9 vs 119,0±69,5 кПа, р=0,29 ; 6,7±1,5 vs 6,3±1,5 m/s, р=0,24 respectively). Statistically significant decrease in AI from 14, 5±11.3 to 11.1±10.6% (p=0.009) and an increase in AC from 0.72±0.25 to 0.87±0.3 mm2 / kPa (p=0.004) were demonstrated as well as decrease in systolic blood pressure (SBP) from 129.5±14.0 to 118.5±14.5 mm Hg (p=0.0001) and an increase in heart rate from 67.9±10.7 to 76.6±12.1 bpm (p=0.0004), lower the level of hemoglobin from 129.6±20.4 to 102.2±16.3 g / l (p=0.00001) and red blood cells from 4.7±0.4 to 3.3±0.6 1012 / l (p=0.00001).Conclusion: In women with breast cancer in the early period after combined chemotherapy with the inclusion of anthracyclines (doxorubicin), taxanes (paclitaxel) and platinum derivatives (cisplatin), there were no increased stiffness of the common carotid artery. Pseudo-positive changes in the form of an increase in the extensibility of the vascular wall and a decrease in the augmentation index are explained by general hemodynamic changes in the form of a decrease in the SBP, an increase in heart rate, as well as anemia during chemotherapy.

Publisher

Intermedservice Ltd

Subject

General Medicine

Reference31 articles.

1. Zamorano J.L., Lancellotti P., Munoz D. R. et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European Heart Journal . 2016 Sep 21;37(36):2768-280. doi:10.1093/eurheartj/ehw211

2. Чазова И.Е, Тюляндин С.А, Виценя М.В. и др. Руководство по диагностике, профилактике и лечению сердечно-сосудистых осложнений противоопухолевой терапии. Часть I. Системные Гипертензии. 2017; № 3: 6-20. DOI: 10.26442/2075-082X_14.3.6-20

3. Чазова И.Е, Тюляндин С.А, Виценя М.В. и др Руководство по диагностике, профилактике и лечению сердечно-сосудистых осложнений противоопухолевой терапии. Часть II-V. Системные Гипертензии. 2017; № 4: 6-19. DOI: 10.26442/2075-082X_15.1.6-20

4. Campia U., Moslehi J., Amiri-Kordestani L. et al. Cardio-Oncology: Vascular and Metabolic Perspectives. A Scientific Statement From the American Heart Association. Circulation. 2019 Mar 26; 139(13): e579–e602. doi: 10.1161/CIR.0000000000000641

5. Herrmann J, Yang E.H., Iliescu C.A. Vascular toxicities of cancer therapies: the old and the new–an evolving avenue.Circulation 2016;133(13):1272–1289. doi: 10.1161/CIRCULATIONAHA.115.018347

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3